Accession Number: | 0000899243-23-001524 |
Date: | 2023-01-06 |
Issuer: | AMYLYX PHARMACEUTICALS, INC. (AMLX) |
Original Submission Date: |
COHEN JOSHUA B
C/O AMYLYX PHARMACEUTICALS, INC.
43 THORNDIKE STREET
CAMBRIDGE, MA 02141
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2023-01-06 | S | 4,122 | a | $36.08 | 2,894,463 | direct | ||
COMMON STOCK | 2023-01-06 | S | 1,846 | a | $36.79 | 2,892,617 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. these sales were automatic and intended to qualify under rule 10b5-1. |
f2 | the price reported in column 4 is a weighted average price. the shares were sold in multiple transactions at prices ranging from $35.59 to $36.58. full information regarding the number of shares sold at each separate price can be furnished to the sec staff upon request. |
f3 | the price reported in column 4 is a weighted average price. the shares were sold in multiple transactions at prices ranging from $36.59 to $37.01. full information regarding the number of shares sold at each separate price can be furnished to the sec staff upon request. |